Evgen Pharma Share Discussion Threads

[mesquida] 15/5/2020 17:48

£50 m market cap does not seem that far-fetched to me.

[mesquida] 15/5/2020 17:44

Zak Mir was speculating about a possible rise to 40p in his webcast this morning, and that was BEFORE the RNS. Could be an interesting few months ahead of us.

[moneymunch] 15/5/2020 17:38

.Surprised this didn't finish higher...potential transformational funding news coming soon, for Covid-19 patient trials...Exciting or what!!!??? Gla :'l

Evgen can confirm that it is in discussions with a potential source of funds that would help pay for a clinical trial in Covid-19 patients, with Evgen providing SFX-01 in support of such a trial.

[moneymunch] 15/5/2020 14:28

The abrupt departure of the CEO suggests rather than charitable, the funding potentially could from a commercial background such as Major pharma, and so hopefully not too long before the next update. Gla :-)

[the stigologist] 15/5/2020 14:22

LifeARC a C4XD partner are the sort of medical research charity foundation who would fund this sort of thing

Interesting C4XD have their own NRF2 pathway molecule

[waterloo01] 15/5/2020 14:22

Almost forgot I had a few of these. I think I bought them at 15/16p late last year. Knew there was a reason I bought in the 1st place and thanks to Timbo for that original insight.

So as the price is where I originally bought, would I buy now if I didn't hold any? Yes, so I have added a few.

[moneymunch] 15/5/2020 14:18

 This looks like a steal at current share price with the very real chance of a stellar RNS ahead, ...is a JV with a Major Pharma on the cards??? , hence the recent rapid departure of the CEO, whereby they may want their man at the helm???.Gla :')

[moneymunch] 15/5/2020 14:13

and some more at 14p..;-)

[moneymunch] 15/5/2020 13:58

Another £3.5k top up for me on the drop at 14.3p which would appear to be a bargain, given the potential Transformational news ahead. Gla :-)

[moneymunch] 15/5/2020 13:25

News expected soon on new CEO, and updates on existing and new developments could drop at anytime, including the high chance of SFX-01 evaluation for Covid-19 imho ( confirmation which arrived today ) . Gla Holders....Potential Transformational news coming on funding, could it be a Major pharma who wanted their man in the mix, hence the abrupt departure of the last CEO???? Excitiing times ;-)

5/12/19

Memorandum of Understanding with The University of Dundee

Evgen Pharma (AIM: EVG) a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces it has entered into a Memorandum of Understanding with the The University of Dundee ("The University") to advance SFX-01 towards a clinical trial in non-alcoholic steatohepatitis ("NASH") and liver fibrosis. Evgen has agreed to supply SFX-01 to support a potential future clinical trial led by John Dillon, Professor of Hepatology and Gastrenterology in the University's School of Medicine.

John Dillon, Professor of Hepatology and Gastrenterology at the University of Dundee's the School of Medicine said: "We are delighted that Evgen will support our plans to undertake a clinical trial on SFX-01 in patients with NASH. Oxidative stress is pivotal to the development of NASH and our research suggests that activation of the Nrf2 pathway, which in turn reduces oxidative stress, can reverse the pathology."

6/2/20

University of Manchester collaboration discovery

Gene signature identified which may determine response to SFX-01 in ER+ breast cancer treatment

Evgen closer to predicting which patients are most likely to benefit from breast cancer drug

Steve Franklin, CEO of Evgen Pharma, said: "This latest data from an eight-year collaboration with Manchester University, and the forthcoming publication, are very positive developments for both the design of future clinical trials and for supporting business development activity with potential partners. The University of Manchester have been tremendous collaborators and we would like to thank them for their continued commitment and enthusiasm.

13/2/20

University of Rochester Collaboration

Evgen Pharma (Evgen) and The University of Rochester School of Medicine and Dentistry have entered into a Memorandum of Understanding to advance SFX-01 towards a clinical trial in chronic kidney disease (CKD).

Thu Le, Professor of Medicine, and Chief of the Division of Nephrology at the University of Rochester Medical Center said: "We are pleased that Evgen will support our plans to undertake a clinical trial on SFX-01 in patients with CKD. Increased oxidative stress is a major molecular underpinning of CKD progression and our research suggests that patients with the GSTM1 null allele may particularly benefit from sulforaphane treatment via SFX-01 dosing."

Dr Stephen Franklin, CEO of Evgen Pharma, commented:

"We are delighted to be supporting the work of such a respected team and prestigious university. We very much hope the proposed trial will generate data demonstrating that SFX-01 could potentially improve the lives of patients suffering from CKD."

[ih_343095] 15/5/2020 13:20

SFX-01 is in trials for a myriad of ailments in clinics internationally. I am certain Evgen examined existing data for covid cases and outcomes. Sulforaphane is an immune system activator and frankly, I am surprised it has taken this long for this news to be hinted. Be well and grow broccoli sprouts.

[ih_343095] 15/5/2020 13:19

SFX-01 is in trials for a myriad of ailments in clinics internationally. I am certain Evgen examined existing data for covid cases and outcomes. Sulforaphane is an immune system activator and frankly, I am surprised it has taken this long for this news to be hinted. Be well and grow broccoli sprouts.

[bumpa33] 15/5/2020 13:19

Same here, I’m wondering - as I did prior - whether whoever is funding the venture also wanted their man/woman in place on the board?

All a bit too coincidental otherwise.

[toffeeman] 15/5/2020 13:16

Well the gap closed!

Staying in for now

[moneymunch] 15/5/2020 13:13

Lol apfindley, missed the boat again and bitter and twisted as usual...why don't you do some research on EVG instead of making comment, SFX-01 could be a panacea for a myriad of diseases and conditions, Covid-19 obviously being one of them. They are in callobaration with several highly prestigious Universities both here and the US....so go and do one. Gla potential Transformational news coming soon!!! :')

[apfindley] 15/5/2020 13:08

Oh dear. Every pharma getting onto the covid train and using it as an excuse to fund trials into covid which they wouldve never of looked into such a thing previously.Desperate way to raise funds.

[moneymunch] 15/5/2020 12:56

This will go again big time just as soon as the profit takers are mopped up....this has most probably been leaking for some time, hence today's Rns....Big news to follow hot on its heels with any luck.Gla :-)

[pre] 15/5/2020 12:54

someone just got spiked on impatience - mr 31018....lost circ.£750 in 12 minutes

[moneymunch] 15/5/2020 12:53

Great suff, and hopefully not too long to find out. Definitely one you wouldn't want be out of over the weekend....:-))))

[timbo003] 15/5/2020 12:49

Good stuff.

So this could be the third Proof of Concept study that someone else is paying for.

My guess is that the counter party is a charitable foundation (or possibly public funding of some sort), rather than private sector

[moneymunch] 15/5/2020 12:48

Wow...;-)))

15/05/2020 12:30pmUK Regulatory (RNS & others)

TIDMEVG

RNS Number : 0864N

Evgen Pharma PLC

15 May 2020

Evgen Pharma plc

("Evgen" or the "Company")

Share price movement

Evgen Pharma plc (AIM: EVG), the clinical stage drug development company focused on the treatment of cancer and neurological conditions, notes the increase in the Company's share price in recent days.

Evgen can confirm that it is in discussions with a potential source of funds that would help pay for a clinical trial in Covid-19 patients, with Evgen providing SFX-01 in support of such a trial.

A further announcement will be made if these discussions are successful.

[bumpa33] 15/5/2020 12:48

Well well, there we go :)

[peanut100] 15/5/2020 12:42

If this catches up with other mkt caps in the sector could be 30p/40p plus

[nobbygnome] 15/5/2020 12:41

And to think I was accused of ramping about a Covid 19 link 🙄!